| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |